507 related articles for article (PubMed ID: 26134438)
1. Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results.
Wang C; Horton JK; Yin FF; Chang Z
Technol Cancer Res Treat; 2016 Oct; 15(5):651-60. PubMed ID: 26134438
[TBL] [Abstract][Full Text] [Related]
2. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
[TBL] [Abstract][Full Text] [Related]
3. Perfusion Parameters in Dynamic Contrast-enhanced MRI and Apparent Diffusion Coefficient Value in Diffusion-weighted MRI:: Association with Prognostic Factors in Breast Cancer.
Lee HS; Kim SH; Kang BJ; Baek JE; Song BJ
Acad Radiol; 2016 Apr; 23(4):446-56. PubMed ID: 26852247
[TBL] [Abstract][Full Text] [Related]
4. Preoperative single fraction partial breast radiotherapy for early-stage breast cancer.
Palta M; Yoo S; Adamson JD; Prosnitz LR; Horton JK
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):37-42. PubMed ID: 21093166
[TBL] [Abstract][Full Text] [Related]
5. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.
Fasmer KE; Bjørnerud A; Ytre-Hauge S; Grüner R; Tangen IL; Werner HM; Bjørge L; Salvesen ØO; Trovik J; Krakstad C; Haldorsen IS
Acta Radiol; 2018 Aug; 59(8):1010-1017. PubMed ID: 29137496
[TBL] [Abstract][Full Text] [Related]
6. Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patients.
Mouawad M; Biernaski H; Brackstone M; Lock M; Yaremko B; Sexton T; Yu E; Dinniwell RE; Lynn K; Hajdok G; Prato FS; Thompson RT; Gelman N; Gaede S
Radiother Oncol; 2019 Feb; 131():60-65. PubMed ID: 30773188
[TBL] [Abstract][Full Text] [Related]
7. Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol.
Charaghvandi RK; van Asselen B; Philippens ME; Verkooijen HM; van Gils CH; van Diest PJ; Pijnappel RM; Hobbelink MG; Witkamp AJ; van Dalen T; van der Wall E; van Heijst TC; Koelemij R; van Vulpen M; van den Bongard HJ
BMC Cancer; 2017 Mar; 17(1):181. PubMed ID: 28274211
[TBL] [Abstract][Full Text] [Related]
8. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
9. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
11. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology.
Merz M; Seyler L; Bretschi M; Semmler W; Bäuerle T
Eur J Radiol; 2015 Apr; 84(4):623-30. PubMed ID: 25641009
[TBL] [Abstract][Full Text] [Related]
13. DCE-MRI-Derived Volume Transfer Constant (K
Ye ZM; Dai SJ; Yan FQ; Wang L; Fang J; Fu ZF; Wang YZ
Technol Cancer Res Treat; 2018 Jan; 17():1533034618765254. PubMed ID: 29642773
[TBL] [Abstract][Full Text] [Related]
14. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy.
Røe K; Muren LP; Rørvik J; Olsen DR; Dahl O; Bakke A; Malinen E
Acta Oncol; 2008; 47(7):1257-64. PubMed ID: 18618299
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
Jensen LR; Garzon B; Heldahl MG; Bathen TF; Lundgren S; Gribbestad IS
J Magn Reson Imaging; 2011 Nov; 34(5):1099-109. PubMed ID: 22002757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
